
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
The Long Run with Luke Timmerman
00:00
Innovations in Cancer Treatment: The TBXT Challenge and CAR-T Cell Success
This chapter focuses on a new prize competition aimed at drug discovery for TBXT, a transcription factor associated with various cancers, offering over $500,000 in prizes. It also highlights advances in CAR-T cell therapies, sharing inspiring stories of patient recoveries and the pivotal figures in this transformative field.
Transcript
Play full episode